Au@CeO 2 nanozyme–based targeted delivery platform for computed tomography–guided synergistic antioxidant/mild photothermal therapy of inflammatory bowel disease

Key Points

• The goal is to develop a nanotheranostic agent for effective treatment of inflammatory bowel disease (IBD).
• Preparation of Au@CeO2 nanozymes@Eudragit S100 for targeted delivery.
• Application of computed tomography for guided therapy.
• Combination of antioxidant and mild photothermal therapies.
• Demonstrated effectiveness in targeting IBD.
• Shown positive outcomes for antioxidant and mild photothermal therapy.
• Indicated potential for enhanced treatment delivery through nanotechnology.